Korean J Hematol 2009; 44(2):
Published online June 30, 2009
https://doi.org/10.5045/kjh.2009.44.2.113
© The Korean Society of Hematology
이희영 정대준 이동규 천광진 유숙원 송서영
강원대학교 의과대학 내과학교실, 진단검사의학교실
Immune thrombocytopenic purpura (ITP) can be classified as primary or secondary according to the presence of an underlying non-malignant or malignant disorder, including lymphoproliferative disorders. The estimated prevalence of ITP in patients with Hodgkin's lymphoma is about 1%, and its clinical course has been reported in approximately 50 patients. ITP is an unusual and poorly documented complication in patients with non-Hodgkin's lymphoma. Some cases have been described in patients who have undergone high-dose chemotherapy and autologous bone marrow/peripheral blood stem cell transplantation. Rare cases appear to be coincidental. Here, we report on a rare case of a 61-year-old man who had ITP after being in a state of complete remission of non-Hodgkin's lymphoma for about 15 months. (Korean J Hematol 2009;44:113-116.)
Keywords Idiopathic thrombocytopenic purpura, Non-Hodgkin's lymphoma, Splenectomy
Korean J Hematol 2009; 44(2): 113-116
Published online June 30, 2009 https://doi.org/10.5045/kjh.2009.44.2.113
Copyright © The Korean Society of Hematology.
이희영 정대준 이동규 천광진 유숙원 송서영
강원대학교 의과대학 내과학교실, 진단검사의학교실
Hui Young Lee, Dae Joon Jeong, Dong Gyu Lee, Kwang jin Chun, Sook Won Ryu, Seo oung Song
Departments of Internal Medicine and Laboratory Medicine, College of Medicine, Kangwon National University, Chuncheon, Korea
Immune thrombocytopenic purpura (ITP) can be classified as primary or secondary according to the presence of an underlying non-malignant or malignant disorder, including lymphoproliferative disorders. The estimated prevalence of ITP in patients with Hodgkin's lymphoma is about 1%, and its clinical course has been reported in approximately 50 patients. ITP is an unusual and poorly documented complication in patients with non-Hodgkin's lymphoma. Some cases have been described in patients who have undergone high-dose chemotherapy and autologous bone marrow/peripheral blood stem cell transplantation. Rare cases appear to be coincidental. Here, we report on a rare case of a 61-year-old man who had ITP after being in a state of complete remission of non-Hodgkin's lymphoma for about 15 months. (Korean J Hematol 2009;44:113-116.)
Keywords: Idiopathic thrombocytopenic purpura, Non-Hodgkin's lymphoma, Splenectomy
José Carlos Jaime-Pérez, Patrizia Aguilar-Calderón, Lorena Salazar-Cavazos, Andrés Gómez-De León, David Gómez-Almaguer
Blood Res 2019; 54(2): 131-136Gak-Won Yun, Young-Jun Yang, Ik-Chan Song, Seung-Woo Baek, Kyu-Seop Lee, Hyo-Jin Lee, Hwan-Jung Yun, Kye-Chul Kwon, Samyong Kim, and Deog-Yeon Jo
Korean J Hematol 2011; 46(2): 128-134Masashi Ohe, and Satoshi Hashino
Korean J Hematol 2011; 46(2): 139-142